FDG PET Findings Post-COVID Vaccinations: Signs of the Times?

Clin Nucl Med. 2021 May 1;46(5):437-438. doi: 10.1097/RLU.0000000000003636.

Abstract

Vaccinations can cause hypermetabolic axillary lymphadenopathy on FDG PET. We present the case of a 71-year-old man who underwent FDG PET/CT for melanoma staging 6 days following a COVID (coronavirus disease) vaccination. Imaging showed a prominent intramuscular mass at the vaccination site, in addition to extensive axillary lymphadenopathy. The mass was compatible with a hematoma at the vaccination site, and the lymphadenopathy was most likely reactive. This case demonstrates unconventional findings in response to a routine vaccination event-findings that, in light of current world events, are likely to be routinely encountered on PET imaging and that should be recognized reactive rather malignant.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines / adverse effects*
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Melanoma / diagnostic imaging
  • Melanoma / immunology
  • Positron Emission Tomography Computed Tomography*
  • Vaccination*

Substances

  • COVID-19 Vaccines
  • Fluorodeoxyglucose F18